FINY vs. BIOY

Last updated Jul 1, 2026

FINY (GraniteShares YieldBOOST Financials ETF) and BIOY (GraniteShares YieldBOOST Biotech ETF) are both Derivative Income funds from GraniteShares. Both are actively managed. At a 0.03 correlation, their price movements are largely independent. Both charge a 1.07% expense ratio.

Performance

FINY vs. BIOY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GraniteShares YieldBOOST Financials ETF (FINY) and GraniteShares YieldBOOST Biotech ETF (BIOY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

FINY

• 1D: 0.04%
• 1M: 2.80%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BIOY

• 1D: 0.30%
• 1M: 1.11%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FINY vs. BIOY - Yearly Performance Comparison

	2026 (YTD)
FINY GraniteShares YieldBOOST Financials ETF	4.75%
BIOY GraniteShares YieldBOOST Biotech ETF	0.99%

Correlation

The correlation between FINY and BIOY is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since May 5, 2026	0.03

Return for Risk

FINY vs. BIOY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Financials ETF (FINY) and GraniteShares YieldBOOST Biotech ETF (BIOY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

FINY vs. BIOY - Drawdown Comparison

The maximum FINY drawdown since its inception was -0.63%, smaller than the maximum BIOY drawdown of -5.07%. Use the drawdown chart below to compare losses from any high point for FINY and BIOY.

Drawdown Indicators

	FINY	BIOY	Difference
Max Drawdown Largest peak-to-trough decline	-0.63%	-5.07%	+4.44%
Current Drawdown Current decline from peak	0.00%	-0.46%	+0.46%
Average Drawdown Average peak-to-trough decline	-0.07%	-2.16%	+2.09%

Volatility

Volatility by Period

	FINY	BIOY	Difference
Volatility (1Y) Calculated over the trailing 1-year period	4.53%	15.83%	-11.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	4.53%	15.83%	-11.30%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	4.53%	15.83%	-11.30%

FINY vs. BIOY - Expense Ratio Comparison

Both FINY and BIOY have an expense ratio of 1.07%.

Dividends

FINY vs. BIOY - Dividend Comparison

FINY's dividend yield for the trailing twelve months is around 3.88%, less than BIOY's 9.46% yield.

Position	TTM
BIOY GraniteShares YieldBOOST Biotech ETF	9.46%
FINY GraniteShares YieldBOOST Financials ETF	3.88%

Frequently Asked Questions

Can I hold both FINY and BIOY in my portfolio?

FINY and BIOY have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, FINY or BIOY?

Both ETFs have the same 1.07% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, FINY or BIOY?

FINY and BIOY have the same expense ratio: 1.07% per year.

Which ETF pays a higher dividend yield, FINY or BIOY?

BIOY has the higher dividend yield at 9.46%, compared with 3.88% for FINY.